Artiva Biotherapeutics, Inc. ARTV Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by Artiva Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The official record: Artiva Biotherapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Artiva Biotherapeutics, Inc.'s retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Artiva Biotherapeutics, Inc.'s retained earnings?
- Artiva Biotherapeutics, Inc. (ARTV) reported retained earnings of -$354.07M in Q1 2026.
- How has Artiva Biotherapeutics, Inc.'s retained earnings changed year-over-year?
- Artiva Biotherapeutics, Inc.'s retained earnings decreased by 32.6% year-over-year, from -$267M to -$354.07M.
- What is the long-term trend for Artiva Biotherapeutics, Inc.'s retained earnings?
- Over 2 years (2023 to 2025), Artiva Biotherapeutics, Inc.'s retained earnings has grown at a 35.0% compound annual growth rate (CAGR), from -$181.31M to -$330.55M.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.